We present the first report of the use of remifentanil and propofol target-controlled infusion to sedate a patient with a difficult airway undergoing awake fibreoptic intubation. This regimen was rapidly titratable, aided suppression of airway reflexes, maintained patient comfort and cooperation and did not compromise spontaneous respiration. The literature regarding infusion rates and potential complications of this technique is reviewed.
The goal of maintaining patient comfort, cooperation and spontaneous respiration while adequately obtunding laryngeal reflexes during awake fibreoptic intubation has been approached in many ways. Clearly local anaesthetic is vital to reduce pain and block airway reflexes, but many anaesthetists feel systemic agents that provide a degree of analgesia, amnesia, sedation and further suppression of reflexes such as coughing are warranted. A combination of infusions of remifentanil and propofol targetcontrolled infusion (TCI) may be a relatively safe method of achieving these goals, given that short plasma half-lives allow rapid titration of depth of sedation and degree of respiratory depression. We present a case report of the use of this sedative regimen, followed by a discussion of the literature regarding dosage and complications reported in the use of remifentanil and propofol TCI for sedation.
CASE HISTORY
A 55-year-old male presented for thyroidectomy for a retrosternal multinodular goitre. He complained of a ten-year history of dysphagia and progressive postural respiratory obstruction. Dyspnoea was particularly marked when lying supine or in the right lateral position. Consequently, he slept semirecumbent on his left side.
On examination he exhibited signs of retrosternal thyroid extension with a positive Pemberton's sign. He was assessed as having a potentially difficult airway. He weighed 109 kg, had a short thick neck capable of minimal extension (having undergone a cervical C3-5 fusion seven years previously), his mouth-opening was less than two fingers' breadth, his dentition was poor and his airway was judged as Mallampati class IV. No clinical signs of hyperthyroidism were found and investigations confirmed that he was euthyroid. Chest X-ray showed minimal tracheal deviation to the right. Computerized tomography (supine) showed a 4 cm long region of marked tracheal compression retrosternally. Flowvolume loops in the sitting position demonstrated no evidence of upper airway obstruction.
In view of the anticipated difficult intubation, an awake nasal fibreoptic intubation was planned, the procedure explained to the patient and consent obtained. The patient was positioned sitting and Co-phenylcaine spray (phenylephrine hydrochloride 0.5%, lignocaine hydrochloride 5%, Paedpharm Pty Ltd) was applied to both nostrils. Superior laryngeal nerve blockade and transtracheal injection of local anaesthetic was not attempted due to the overlying mass of thyroid tissue. Midazolam 2 mg was given intravenously and an oxygen catheter (4 l/min) was inserted into the right nostril. Monitoring included pulse oximetry, non-invasive blood pressure and electrocardiogram. Infusions of remifentanil 0.05 µg/kg/min and propofol TCI 0.5 µg/ml were commenced 10 minutes prior to airway manipulation. A size 7 armoured tube was loaded onto the fibreoptic bronchoscope (Olympus, 3 mm outside diameter) which was then inserted into the left nostril. The bronchoscope was advanced into the nasopharynx, where difficulty was experienced visualising the larynx (probably due to bronchoscope positioning and patient anatomy). The endotracheal tube was then advanced blind until respiration could be detected through the tube via audible breath sounds and tube misting. The patient had no discomfort but suffered a minor nose-bleed, which made subsequent visualisation problematic. Lignocaine 4% in 2 ml aliquots was sprayed through the bronchoscope when the epiglottis came into view, resulting in mild patient coughing. The vocal cords were never adequately seen, but blind advancement of the bronchoscope resulted in a view of the tracheal rings and the tube was advanced into the trachea without the patient coughing. The endotracheal tube cuff was inflated and a capnograph showed carbon dioxide expiration (40 mmHg). During the period of endoscopy oxygen saturation was 99%, while heart rate ranged from 60 to 70 beats/min. Patient comfort, cooperation and verbal contact was maintained throughout. General anaesthesia was then induced by increasing propofol to a target of 3 µg/ml and remifentanil to 0.25 µg/kg/min.
The operation proceeded uneventfully and the patient was successfully extubated with no postoperative evidence of airway obstruction. Direct questioning later revealed that the patient had no recollection of events after insertion of the nasal oxygen catheter.
DISCUSSION
Recently the use of remifentanil and propofol for awake fibreoptic intubation has been reported in the literature, although no report utilized propofol TCI. Neidhart et al published a series of 40 patients with difficult airways undergoing nasal fibreoptic intubation 1 . They used topical lignocaine, a propofol infusion at 2 mg/kg/h and remifentanil 0.05 µg/kg/min (varied to maintain respiration). No subject became hypoxic or hypercarbic. Only one patient had a blood pressure or heart rate change >30%. Coughing occurred in five patients and 37 had no recall of the procedure. They concluded a combination of remifentanil and propofol is a safe regimen for fibreoptic intubation. Another descriptive study 2 examined fixed rate remifentanil infusion (0.05 µg/kg/min) in addition to bolus propofol (1 mg/kg) in 26 children aged 3 to 14 years undergoing diagnostic flexible bronchoscopy. Though describing their technique as one of sedation, verbal contact and cooperation was not maintained, adequate depth of anaesthesia/sedation being defined as lack of movement or coughing. All patients breathed spontaneously and no episode of hypoxia, hypercapnoea, bronchospasm, or rigidity occurred. No patient required assisted respiration. Reusche and Egan performed awake fibreoptic intubation in a case of Ludwig's angina, using remifentanil in combination with midazolam and droperidol, but without propofol 3 . The remifentanil infusion rate was varied from 0.05 µg/kg/min to 0.175 µg/kg/min, except for a period during the intubation in which remifentanil was ceased because the patient was deemed too sedated. Spontaneous respiration was maintained and they noted the benefit of the rapid speed of offset of remifentanil in this setting.
Although none of these studies described significant complications, a number of problems have been reported when using remifentanil for general sedation. These include mild itching 4 and nausea [4] [5] [6] , although symptoms do not persist once the infusion is ceased. Apnoea is a feared potential complication of remifentanil in the setting of a difficult airway that may obstruct. Apnoea was a problem in Litman's chart reviews of 30 patients undergoing 40 painful medical procedures (such as bone marrow aspiration) under benzodiazepine bolus and remifentanil infusion sedation 7, 8 . Depressed respiration occurred in 34 of the 40 procedures, probably because of the relatively high doses of remifentanil employed (bolus of 1 µg/kg followed by an infusion titrated upwards from 0.1 µg/kg/min to a mean of 0.5 µg/kg/min). A number of authors have sought to determine suitable remifentanil infusion rates for general sedation 6, 9 or as an adjunct to local and regional anaesthesia 4, 5 . Doses of 0.1 µg/kg/min and higher are associated with respiratory depression and remifentanil infusion rates of approximately 0.05 µg/kg/min were recommended for sedation. Banenco et al 10 have described the time course of respiratory depression following a bolus of 0.5 µg/kg in unpremedicated volunteers. Maximum depression (but no apnoea) occurred after 2.5 minutes approximately, with full recovery by 15 minutes. This rapid onset and offset supports the titration of remifentanil infusions to maintain spontaneous ventilation.
Midazolam has been shown to have synergistic sedative and respiratory depressant effects when combined with remifentanil 6 . Gold et al 11 attempted to define the interrelation of midazolam and remifentanil in a double-blind randomized trial involving 159 patients undergoing outpatient procedures.
Patients who received 2 mg of midazolam required remifentanil infusions of 0.07 µg/kg/min while those receiving remifentanil alone required 0.12 µg/kg/min to maintain patient comfort and adequate sedation. Avramov et al 12 examined the infusion rate of remifentanil required to maintain sedation when coupled with an intravenous bolus of placebo, or 2, 4 or 8 mg midazolam in 81 women undergoing breast biopsy. Midazolam produced a dose-dependent increase in sedation, amnesia and incidence of bradypnoea. Midazolam appears to be synergistic with remifentanil with respect to respiratory depression, amnesia and production of hypnosis and remifentanil infusion rates should be reduced accordingly.
We chose a target-controlled infusion of propofol because it allows rapid and predictable alteration of the level of sedation, while minimizing systemic sideeffects caused by overshoot or undershoot compared with intermittent boluses or manual change of infusion rate 13 . A number of studies cited by Janzen et al 14 have examined propofol TCI systems in order to define appropriate targets for different depths of sedation and anaesthesia. There is significant interpatient variability, but targets in the range of 1 to 2 µg/ml are required for sedation with propofol alone. We used propofol TCI 0.5 µg/ml, being mindful of its combination with midazolam and remifentanil in this patient. We were prepared to titrate propofol rate upwards or downwards but this was not required.
We conclude that titrated low dose remifentanil (0.05 µg/kg/min), in combination with propofol TCI (target 0.5 µg/ml) appears to be a safe method of providing sedation for awake fibreoptic intubation in the difficult airway. The rapid titration of effect available with both drugs allows rapid variation in the depth of sedation, the degree of respiratory depression and the suppression of airway reflexes. In our opinion further evaluation of this technique is warranted.
